Access to anti-retroviral drugs, female in Zimbabwe
Zimbabwe: Access to anti-retroviral drugs, female was 98.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Zimbabwe, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Zimbabwe recorded 98.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
That represents a change of up 58.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Zimbabwe peaked at 98.0% in 2022 and was at its lowest, 0.0%, in 2000.
Zimbabwe ranks 1st of 141 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Zimbabwe, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 2.0% | +100.0% |
| 2006 | 4.0% | +100.0% |
| 2007 | 8.0% | +100.0% |
| 2008 | 11.0% | +37.5% |
| 2009 | 17.0% | +54.5% |
| 2010 | 31.0% | +82.4% |
| 2011 | 43.0% | +38.7% |
| 2012 | 48.0% | +11.6% |
| 2013 | 52.0% | +8.3% |
| 2014 | 62.0% | +19.2% |
| 2015 | 67.0% | +8.1% |
| 2016 | 74.0% | +10.4% |
| 2017 | 83.0% | +12.2% |
| 2018 | 87.0% | +4.8% |
| 2019 | 91.0% | +4.6% |
| 2020 | 92.0% | +1.1% |
| 2021 | 94.0% | +2.2% |
| 2022 | 98.0% | +4.3% |
| 2023 | 98.0% | +0.0% |
| 2024 | 98.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.3% | 0.0% | 17.0% | 10 |
| 2010s | 63.8% | 31.0% | 91.0% | 10 |
| 2020s | 96.0% | 92.0% | 98.0% | 5 |
Countries ranked near Zimbabwe
More gender data for Zimbabwe
- Child population (UN estimates and projections) 6,958 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.695 % change on previous year (2030)
- Population 11,652 (2030)
- Working-age population (UN estimates and projections) 11,652 (2030)
- Population (UN estimates and projections), annual growth rate 2.58 % change on previous year (2030)
- Age population, age 00, female, interpolated 239,901 (2025)
- Age population, age 00, male, interpolated 244,202 (2025)
- Age population, age 01, female, interpolated 236,403 (2025)
- Age population, age 01, male, interpolated 240,452 (2025)
- Age population, age 02, female, interpolated 234,239 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Zimbabwe?
- Access to anti-retroviral drugs, female in Zimbabwe was 98.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Zimbabwe?
- The highest recorded value was 98.0% in 2022.
- What is the lowest access to anti-retroviral drugs, female recorded in Zimbabwe?
- The lowest recorded value was 0.0% in 2000.
- How does Zimbabwe rank for access to anti-retroviral drugs, female?
- Zimbabwe ranks 1st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Zimbabwe?
- Over the last ten years it is up 58.1%. The long-run trend across the full record is volatile.
- Where does this Zimbabwe data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.